×
About 9,254 results

ALLMedicine™ Angina Pectoris Center

Research & Reviews  3,261 results

Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Tria...
https://doi.org/10.1159/000515376
Cardiology Steigen T, Holm NR et. al.

Apr 13th, 2021 - In the treatment of left main coronary artery (LMCA) disease, patients' age may affect the clinical outcome after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). This study stratified the clinical outcome accord...

Effects of SGLT2 inhibitor on ischemic events stemming from atherosclerotic coronary di...
https://doi.org/10.1097/FJC.0000000000001018
Journal of Cardiovascular Pharmacology; Ye G, Wang S et. al.

Apr 12th, 2021 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to reduce cardiovascular complications of type 2 diabetes mellitus. However, the beneficial effects of SGLT2 inhibition are mainly associated with decline in hospitalization and dea...

Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular ev...
https://doi.org/10.1016/j.numecd.2021.01.024
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lu YW, Tsai YL et. al.

Apr 3rd, 2021 - Sarcopenia is a clinical syndrome that features muscle atrophy and weakness, and has been associated with cardiovascular events and poor clinical outcomes. Recently, the sarcopenia index (SI) was developed as a simple screening tool based upon the...

Pre-operative assessment of patients undergoing spinal cord stimulation for refractory ...
https://doi.org/10.1093/pm/pnab105
Pain Medicine (Malden, Mass.); Langford B, Hunt C et. al.

Mar 18th, 2021 - Spinal cord stimulation (SCS) is used to treat a variety of chronic pain conditions refractory to more conservative management including refractory angina pectoris. We identified thirty-one patients who underwent SCS implantation for the indicatio...

Abdominal Aortic Intima-Media Thickness Predicts Coronary Artery Disease Severity in Pa...
https://doi.org/10.1177/0003319721998853
Angiology Cirakoglu OF, Karadeniz AG et. al.

Mar 5th, 2021 - Accurately identifying coronary artery disease (CAD) is the key element in guiding the work-up of patients with suspected angina. Thickening of the arterial wall is a hallmark of atherosclerosis. Therefore, the main purpose of this study was to de...

see more →

Guidelines  5 results

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

Recommendations for advancing the care of Canadians living with refractory angina pecto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723022
The Canadian Journal of Cardiology; McGillion M, L'Allier PL et. al.

Jul 8th, 2009 - Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.|2009|McGillion M,L'Allier PL,Arthur H,Watt-Watson J,Svorkdal N,|epidemiology,therapy,epidemiology,

Resting Heart Rate in Cardiovascular Disease
https://www.sciencedirect.com/science/article/pii/S0735109707018232
Journal of the American College of Cardiology;

Dec 11th, 2006 - The importance of resting heart rate (HR) as a prognostic factor and potential therapeutic target is not yet generally accepted. Recent large epidemiologic studies have confirmed earlier studies that showed resting HR to be an independent predicto...

KAPSPARGO SPRINKLE (metoprolol succinate)
https://www.kapspargosprinklerx.com

Kapspargo Sprinkle™ extended-release capsules are for the treatment of hypertension, angina pectoris, and heart failure. Learn more here.

see more →

Drugs  1,305 results see all →

Clinicaltrials.gov  4,607 results

Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Tria...
https://doi.org/10.1159/000515376
Cardiology Steigen T, Holm NR et. al.

Apr 13th, 2021 - In the treatment of left main coronary artery (LMCA) disease, patients' age may affect the clinical outcome after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). This study stratified the clinical outcome accord...

Metoprolol tartrate - metoprolol tartrate tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14836185-13ab-4838-b038-3cbd2bdd1acf

Apr 13th, 2021 - Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive agents. Angina Pectoris Metoprolol tartrate tablets are indicated in the long-term treat...

Isosorbide mononitrate - isosorbide mononitrate tablet, extended release-American Health Packaging
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bed177b1-2d7a-4abc-9444-f5d0fbe93ae9

Apr 13th, 2021 - Isosorbide Mononitrate Extended-Release Tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in abort...

Propranolol hydrochloride - propranolol hydrochloride capsule, extended release-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bde91bcf-c484-4b19-a160-ecdd3f64fba7

Apr 13th, 2021 - Propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride extend...

Effects of SGLT2 inhibitor on ischemic events stemming from atherosclerotic coronary di...
https://doi.org/10.1097/FJC.0000000000001018
Journal of Cardiovascular Pharmacology; Ye G, Wang S et. al.

Apr 12th, 2021 - Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to reduce cardiovascular complications of type 2 diabetes mellitus. However, the beneficial effects of SGLT2 inhibition are mainly associated with decline in hospitalization and dea...

see more →

News  73 results

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.staging.medscape.com/viewarticle/939965

Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

Advisory Panel Balks at Neovasc Reducer for Refractory Angina
https://www.medscape.com/viewarticle/939965

Oct 27th, 2020 - More than 10 hours of testimony and debate failed to convince a US Food and Drug Administration (FDA) expert advisory panel that existing evidence reasonably supports a premarket approval (PMA) application for the Neovasc Reducer device. The Reduc...

Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes
https://care.diabetesjournals.org/content/42/11/2019
Diabetes Care;

Aug 31st, 2019 - Oxygen supplementation has been a cornerstone in the initial treatment of individuals with acute coronary syndrome. While consensus for oxygen supplementation exists for patients with hypoxia, oxygen supplementation has also been routinely used in...

Cognitive Decline May Accelerate After Ischemic Events
https://www.medscape.com/viewarticle/914656

Jun 18th, 2019 - After a diagnosis of myocardial infarction (MI) or angina pectoris, individuals enrolled in the English Longitudinal Study of Aging (ELSA) showed more accelerated cognitive decline than those who remained free of coronary heart disease (CHD). The ...

Nitroglycerin - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK482382/
Kim,K.,et al

Mar 1st, 2019 - Nitroglycerin is a vasodilatory drug that is used primarily to provide relief from anginal chest pain. Nitroglycerin has been FDA approved since 2000 and was first sold by Pfizer under the brand name Nitrostat. It is currently FDA approved for the...

see more →

Patient Education  3 results see all →